NYMC Faculty Publications

Neuroendovascular Management of Emergent Large Vessel Occlusion: Update on the Technical Aspects and Standards of Practice by the Standards and Guidelines Committee of the Society of NeuroInterventional Surgery

DOI

10.1136/neurintsurg-2017-013554

Journal Title

Journal of Neurointerventional Surgery

First Page

315

Last Page

320

Document Type

Article

Publication Date

March 2018

Department

Neurosurgery

Abstract

Acute ischemic stroke (AIS) is the fifth leading cause of death, and remains the leading cause of disability in the USA.1 There are an estimated 680 000 new strokes per year in the USA, with a mortality rate of 53–94%, and with an even greater morbidity.2 It is estimated that 3–22% of these patients are candidates for endovascular therapy.3–6 In addition to baseline stroke severity, emergent large vessel occlusion (ELVO) has been shown to be an independent predictor of poor outcome at 6 months.3 4 While intravenous recombinant tissue plasminogen activator (IV r-tPA) has proven efficacious predominantly for small cerebral vessel occlusions, endovascular therapies, including stent retriever based, aspiration based mechanical thrombectomy techniques, and intra-arterial administration of thrombolytic agents, have been shown to achieve higher rates of recanalization in patients with ELVO.7–10 The purpose of this document is to provide an update and critical assessment of technical aspects of the mechanical thrombectomy procedure.

Comments

Please see the work itself for the complete list of authors

Link to Full Text

Share

COinS